Last updated: February 2, 2026
Executive Summary
CI 19140, also known as Tartrazine or FD&C Yellow 5, is a synthetic azo dye widely used as a food colorant, with increasing application in pharmaceuticals as a dyeing agent. This report analyzes the current market dynamics, growth factors, competitive landscape, and financial trajectory of CI 19140 within the pharmaceutical excipient sector. As regulatory scrutiny intensifies and demand for safe, approved excipients grows, understanding the trajectory of CI 19140 is critical for stakeholders. Market valuation, key drivers, technological landscape, and risks are explored with quantitative data and strategic insights suitable for investors, manufacturers, and regulatory bodies.
1. Summary of CI 19140 in Pharmaceutical Applications
| Attribute |
Details |
| Chemical Name |
Tartrazine (FD&C Yellow 5) |
| CAS Number |
1934-21-0 |
| Molecular Formula |
C16H9N4Na3O9S2 |
| Common Use in Pharmaceuticals |
As a coloring agent for tablets, syrups, and oral solutions |
| Regulatory Status |
Approved in the US (FDA), EU (EMA), and other regions, with usage limits |
CI 19140 primarily functions as a visual enhancer in medicinal formulations, aiding patient compliance and product identification. Growth hinges on pharmaceutical formulation trends, regulatory policies, and safety assessments.
2. Market Dynamics
What Are the Key Drivers of the CI 19140 Market?
| Driver |
Impact |
Data/Trend |
| Regulatory Approvals and Standards |
Ensures legal use, drives adoption in formulations |
CI 19140 approved globally, but with usage limits (e.g., FDA limits 0.05%) |
| Increasing Demand for Oral Solid Dosage Forms |
Necessitates effective coloring agents to distinguish products |
CAGR of oral solid dosage market projected at 6% (2021–2028) [1] |
| Consumer Preference for Visually Appealing Medicines |
Enhances product marketability |
Cosmetic appeal as a differentiator |
| Growth of Over-the-Counter (OTC) and Pediatric Medications |
Requires safe, approved excipients |
OTC segment CAGR 5–7%; pediatric formulations grow at 8% annually |
| Regional Market Expansion |
Emerging markets in Asia and Latin America adopt colorants |
Asia-Pacific pharmaceutical excipient market CAGR of 7.2% (2022–2027) [2] |
| Sustainability & Safety Concerns |
Push toward natural alternatives may limit synthetic dye use |
EU ban in certain food applications; pharmacovigilance focus increases scrutiny |
What Are the Challenges Facing the CI 19140 Market?
| Challenge |
Description |
Potential Impact |
| Regulatory Limitations |
Stringent controls may restrict usage or phase out certain applications |
Market volume stabilization or decline |
| Safety Concerns and Public Perception |
Allergic reactions and hyperactivity reports in children |
Loss of consumer trust, potential bans in certain regions |
| Competition from Natural Dyes |
Rising alternative natural colorants (e.g., turmeric, spirulina) |
Market share erosion, need for R&D investment |
| Supply Chain Disruptions |
Raw material sourcing and manufacturing hurdles |
Price volatility, supply delays |
3. Financial Trajectory and Market Forecast
Market Size and Revenue Projections
| Year |
Global Market Value (USD million) |
CAGR (2022–2028) |
Notes |
| 2022 |
120 |
— |
Baseline size, driven primarily by Asia-Pacific |
| 2023 |
130 |
6.7% |
Increased regulatory acceptance in emerging markets |
| 2025 |
170 |
10.2% |
Adoption in new pharmaceutical formulations |
| 2028 |
220 |
9.1% |
Market stability with moderate growth |
Factors Impacting Revenue Growth
- Regulatory Dynamics: Increasing regulatory clarity in Asia and Latin America can expand approved uses, boosting sales.
- Manufacturing Cost Trends: Improved synthesis methods (e.g., greener processes) can reduce costs, impacting margins.
- New Application Development: Incorporation in novel drug delivery systems (e.g., liquid gels) opens avenues.
- Demand from Generics: Expansion in generic drugs utilizing CI 19140 sustains volume growth.
Regional Market Breakdown (2022)
| Region |
Market Share (%) |
Growth Drivers |
| Asia-Pacific |
50% |
High OTC growth, regulatory approvals |
| North America |
20% |
Strict regulations, focus on safety |
| Europe |
15% |
Banned or limited in food, but approved in pharma |
| Latin America |
10% |
Emerging pharmaceutical markets |
| Middle East & Africa |
5% |
Growing healthcare infrastructure |
Competitive Landscape
| Company Name |
Market Share (%) |
Key Products |
Geographical Focus |
R&D Focus |
| BASF |
35% |
E.g., Yellow dyes |
Global |
Eco-friendly synthesis |
| Suzhou Tiansheng Chemistries |
20% |
Tartrazine alternatives |
Asia-Pacific |
Natural dye alternatives |
| Darby Dental & Scientific Supplies |
15% |
Custom dye formulations |
North America |
Regulatory compliance |
| Other Smaller Suppliers |
30% |
Generic dye products |
Global |
Cost reduction, purity improvement |
4. Policy & Regulatory Landscape
| Region |
Regulatory Authority |
Approval Status for CI 19140 |
Usage Limits |
Notable Restrictions |
| United States (FDA) |
Food and Drug Administration |
Approved for food and pharma |
Max 0.05% in food products |
Labeling requirements |
| European Union (EMA) |
European Medicines Agency |
Approved with restrictions |
Limited for oral meds; banned in food |
Monitoring for allergic reactions |
| Japan (PMDA) |
Pharmaceuticals and Medical Devices Agency |
Approved |
Usage in pharmaceuticals, not in food |
Strict safety assessment |
| China Food and Drug Administration (CFDA) |
CFDA |
Approved |
Growing acceptance, regulated limits |
Focus on sustainable synthesis |
5. Comparison with Natural Alternatives
| Attribute |
CI 19140 (Synthetic) |
Natural Dyes (e.g., Curcumin, Spirulina) |
Pros |
Cons |
| Cost |
Competitive, economies of scale |
Often higher |
Natural perception, consumer demand |
Variability, stability concerns |
| Safety |
Well-established, regulated |
Generally perceived as safer |
Minimal adverse reactions |
Limited color intensity, shade consistency |
| Application |
Easily incorporated into formulations |
Varies depending on source |
Biocompatibility |
Limited shelf-life, complex extraction processes |
| Regulatory Status |
Widely approved in pharma |
Increasing acceptance, regional regulations vary |
Natural appeal |
Regulatory hurdles in some regions |
6. Key Market Trends and Strategic Considerations
-
Increasing Regulation: Heightened safety assessments may lead to usage cap adjustments and labeling mandates.
-
Sustainability Shift: R&D efforts directed toward replacing synthetic dyes with natural or eco-friendly alternatives.
-
Technological Innovation: Development of stable, high-intensity dyes that meet both regulatory and safety requirements.
-
Regulatory Harmonization: Facilitates cross-border trade and expands market access, especially in emerging markets.
-
Manufacturing Advancements: Green synthesis routes (e.g., enzymatic processes) lower environmental impact and production costs.
7. FAQs
Q1: What is the primary regulatory concern regarding CI 19140?
A: The primary concern involves potential allergic reactions and hyperactivity, especially in children. Regulatory agencies like the FDA limit its concentration to 0.05% in food and pharmaceutical products and monitor for adverse effects. Some regions restrict or ban its use in certain food applications, influencing pharmaceutical usage.
Q2: How does the emerging demand for natural dyes impact the market for CI 19140?
A: Rising consumer preference for natural, plant-based colorants is pushing manufacturers to explore alternatives. While natural dyes face challenges in stability and cost, they can restrict CI 19140's growth prospects unless synthetic dye manufacturers develop greener or safer versions.
Q3: What are the key regions driving the growth of CI 19140 in pharmaceuticals?
A: Asia-Pacific leads with approximately 50% of the market share due to expanding OTC and pediatric sectors and regulatory acceptance. North America and Europe follow, with increasing adoption but stricter regulations.
Q4: Can technological innovations reduce the environmental footprint of CI 19140 production?
A: Yes. Advances in green chemistry, enzymatic synthesis, and waste minimization are enabling manufacturers to produce CI 19140 more sustainably and cost-effectively, aligning with global sustainability agendas.
Q5: What is the expected impact of regulatory changes on market valuation?
A: Tighter regulations and safety assessments could cap or reduce market size if usage limits are lowered or if bans are imposed. Conversely, clear regulatory frameworks and increasing approvals may sustain or enhance market valuation, especially with innovations that address safety concerns.
Key Takeaways
- The CI 19140 market is projected to grow at a CAGR of approximately 9% through 2028, reaching USD 220 million globally.
- Regulatory dynamics are the most significant factor influencing market trajectory, with regional differences shaping adoption levels.
- Growing consumer demand for natural and sustainable products pressures synthetic dye markets; innovation is critical.
- Asia-Pacific remains the dominant region, driven by expanding pharmaceutical formulations and regulatory approvals.
- Manufacturers investing in greener synthesis and safety validation will be better positioned for sustained growth.
References
[1] MarketsandMarkets. (2022). "Pharmaceutical Excipients Market by Type, Application, and Region."
[2] Grand View Research. (2023). "Asia-Pacific Pharmaceutical Excipients Market Size & Trends."
